Ascorers
,NR 566 Final Exam Questions & Answers
1. Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin) are used
clinically as:
A. First-line treatments for hypogonadism
B. Alternatives for hormone replacement therapy
C. Primary therapies for bacterial vaginosis
D. Treatments for Parkinson's disease
Answer: B. Alternatives for hormone replacement therapy
Explanation: According to Page 1, line 1, raloxifene and bisphosphonates
like alendronate and calcitonin serve as alternatives for hormone
replacement therapy. These medications help manage conditions like
osteoporosis without the drawbacks of estrogen therapy, making them
valuable options for patients who cannot or should not take traditional HRT.
...
2. Selective Estrogen Receptor Modulators (SERMs) such as tamoxifen,
toremifene, and raloxifene are characterized by their ability to:
A. Completely block all estrogen receptors throughout the body
B. Provide estrogen benefits in some tissues while avoiding its drawbacks in
others
C. Stimulate progesterone production exclusively
D. Act as androgens in breast tissue
Answer: B. Provide estrogen benefits in some tissues while avoiding its
drawbacks in others
Explanation: As noted on Page 1, line 2, SERMs like tamoxifen,
Ascorers
, toremifene, and raloxifene are unique because they provide the beneficial
effects of estrogen (such as bone protection) in certain tissues while acting
as estrogen antagonists in others (like breast tissue), thereby avoiding some
of the drawbacks associated with estrogen therapy.
...
3. A 10-14 day course of which medication is the recommended treatment for
dysfunctional uterine bleeding?
A. Estradiol
B. Progestin
C. Tamoxifen
D. Metronidazole
Answer: B. Progestin
Explanation: Page 1, line 3 specifically states that dysfunctional uterine
bleeding is treated with a 10-14 day course of progestin. Progestins help
stabilize the endometrial lining and regulate the bleeding pattern, providing
an effective hormonal management strategy for this condition.
...
4. For a patient with amenorrhea, progestin is administered to:
A. Stimulate ovulation
B. Induce menstrual flow
C. Increase estrogen production
D. Prevent endometrial cancer
Ascorers
, Answer: B. Induce menstrual flow
Explanation: According to Page 1, line 4, progestin helps induce menstrual
flow in patients with amenorrhea. By providing progestin and then
withdrawing it, a withdrawal bleed can be triggered, which helps establish a
menstrual cycle and provides endometrial protection.
...
5. In a patient with amenorrhea and low estrogen levels, progestin should be
given for:
A. 1-2 days
B. 5-10 days
C. 14-21 days
D. 30 days continuously
Answer: B. 5-10 days
Explanation: Page 1, line 5 indicates that when amenorrhea is accompanied
by low estrogen levels, progestin should be administered for 5-10 days. This
regimen is sufficient to induce a withdrawal bleed in patients with an
estrogen-primed endometrium.
...
6. Long-term progestin therapy provides which important protective benefit?
A. Protection against breast cancer
B. Protection against endometrial cancer
C. Protection against ovarian cancer
D. Protection against cervical cancer
Ascorers
,NR 566 Final Exam Questions & Answers
1. Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin) are used
clinically as:
A. First-line treatments for hypogonadism
B. Alternatives for hormone replacement therapy
C. Primary therapies for bacterial vaginosis
D. Treatments for Parkinson's disease
Answer: B. Alternatives for hormone replacement therapy
Explanation: According to Page 1, line 1, raloxifene and bisphosphonates
like alendronate and calcitonin serve as alternatives for hormone
replacement therapy. These medications help manage conditions like
osteoporosis without the drawbacks of estrogen therapy, making them
valuable options for patients who cannot or should not take traditional HRT.
...
2. Selective Estrogen Receptor Modulators (SERMs) such as tamoxifen,
toremifene, and raloxifene are characterized by their ability to:
A. Completely block all estrogen receptors throughout the body
B. Provide estrogen benefits in some tissues while avoiding its drawbacks in
others
C. Stimulate progesterone production exclusively
D. Act as androgens in breast tissue
Answer: B. Provide estrogen benefits in some tissues while avoiding its
drawbacks in others
Explanation: As noted on Page 1, line 2, SERMs like tamoxifen,
Ascorers
, toremifene, and raloxifene are unique because they provide the beneficial
effects of estrogen (such as bone protection) in certain tissues while acting
as estrogen antagonists in others (like breast tissue), thereby avoiding some
of the drawbacks associated with estrogen therapy.
...
3. A 10-14 day course of which medication is the recommended treatment for
dysfunctional uterine bleeding?
A. Estradiol
B. Progestin
C. Tamoxifen
D. Metronidazole
Answer: B. Progestin
Explanation: Page 1, line 3 specifically states that dysfunctional uterine
bleeding is treated with a 10-14 day course of progestin. Progestins help
stabilize the endometrial lining and regulate the bleeding pattern, providing
an effective hormonal management strategy for this condition.
...
4. For a patient with amenorrhea, progestin is administered to:
A. Stimulate ovulation
B. Induce menstrual flow
C. Increase estrogen production
D. Prevent endometrial cancer
Ascorers
, Answer: B. Induce menstrual flow
Explanation: According to Page 1, line 4, progestin helps induce menstrual
flow in patients with amenorrhea. By providing progestin and then
withdrawing it, a withdrawal bleed can be triggered, which helps establish a
menstrual cycle and provides endometrial protection.
...
5. In a patient with amenorrhea and low estrogen levels, progestin should be
given for:
A. 1-2 days
B. 5-10 days
C. 14-21 days
D. 30 days continuously
Answer: B. 5-10 days
Explanation: Page 1, line 5 indicates that when amenorrhea is accompanied
by low estrogen levels, progestin should be administered for 5-10 days. This
regimen is sufficient to induce a withdrawal bleed in patients with an
estrogen-primed endometrium.
...
6. Long-term progestin therapy provides which important protective benefit?
A. Protection against breast cancer
B. Protection against endometrial cancer
C. Protection against ovarian cancer
D. Protection against cervical cancer
Ascorers
